Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.
about
Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose.Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquineDisposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.CYP2D6 in the metabolism of opioids for mild to moderate pain.Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism.Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and ChineseA comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation.Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.A review and assessment of potential sources of ethnic differences in drug responsiveness.Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer painNew developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease".Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Metabolic phenotypes and colorectal neoplasia.The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease.Prediction of xenobiotic metabolism by non-invasive methods.Confirmation of recent heroin abuse: Accepting the challenge.Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes.Ecogenetics: from ecology to health.Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.CYP2D6-inhibiting drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment--a Swedish, register-based case-crossover study.Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl.A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by LC-MS.Dispositional study of opioids in mice pretreated with sympathomimetic agents.Testosterone sulphation and glucuronidation in the human liver: interindividual variability.Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors.Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat.Lower urinary recovery of oral morphine in Saudi Arabian cancer patients compared to Swedish cancer patients.Pharmacokinetics of naproxen, its metaboliteO-desmethylnaproxen, and their acyl glucuronides in humans
P2860
Q28367979-5B8B0424-8A32-4672-89D3-DFA238C15562Q28609389-98FD9DFE-5D54-440C-90FF-337383D89F5AQ28609390-D9DBD52F-30E6-498F-8B80-A7D4E0A85CD8Q33451969-FCEB77FC-6459-4C67-BE0F-59CA53786BACQ34178485-D4732D77-A535-400B-B901-952C6702DE22Q34311091-7445A914-6E5A-4553-A9DF-91589B1A1224Q34358813-1249EF9D-FEBE-4061-B416-AAB1AC102E9FQ34358854-CB6A626A-8807-49CF-9A88-8C45B454632BQ34398035-14CAAD97-A49C-4E13-A613-444C806370D8Q34638720-E2B867D1-FC11-4A12-BEB1-2FD99873E929Q35058027-7D949761-EABB-4B98-BDCF-4284924FE570Q35157993-A5C33BDD-C4B2-43CE-BD34-02DE61591077Q35217493-24E92833-BA20-4031-BCB5-A7DD76C67A1EQ35728885-8B10EC7C-2D12-4DC5-9BDD-9661AB870D57Q35866790-A8EDAA19-CDDF-4D0D-BCD1-5709F4C2C0B2Q35876954-580E2D78-367F-440A-8FBD-2FC5CE4361D0Q36418621-C95215AD-9EF5-4404-BAE7-C955CCF74551Q37178666-CD9EE664-CBC5-4044-B8BA-62C522371D6EQ37829237-78F8B074-A83A-4D75-80AD-8784D932260AQ39417530-D35355B8-1A50-4AFD-9904-058293D8AC59Q40932226-C7D1B0F3-46BC-4165-BC0E-A568D490C07EQ41513150-1007F410-B474-4D8B-9BCD-E1D56271151DQ42097867-30F8496F-D691-4984-943E-03FE48AEB5CCQ44345641-F75266F5-DA0C-4C9B-B6C6-25DE9A520B43Q46979699-E32CCF9A-0F66-4BCC-AABE-0EFB27238730Q48392462-145B5D38-9E85-415C-91CF-B0C503FBE104Q48451984-8BFA5BE0-3EA3-4935-8F34-3F8D8AFF84AEQ50926216-F1A8D277-D213-4B95-872D-A476F782B8CDQ51739314-B9593E91-E8D3-4CFC-B026-02F098CAE2C7Q52302286-31AFAFA4-32A6-40BA-9572-733338C1055BQ54672775-92AE8316-B7DA-421D-B303-DBB80DE34EFFQ56288636-814E5B1D-3A26-4F59-AB37-7ADE0582051A
P2860
Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Interindividual and interethni ...... nd glucuronidation of codeine.
@ast
Interindividual and interethni ...... nd glucuronidation of codeine.
@en
Interindividual and interethni ...... nd glucuronidation of codeine.
@nl
type
label
Interindividual and interethni ...... nd glucuronidation of codeine.
@ast
Interindividual and interethni ...... nd glucuronidation of codeine.
@en
Interindividual and interethni ...... nd glucuronidation of codeine.
@nl
prefLabel
Interindividual and interethni ...... nd glucuronidation of codeine.
@ast
Interindividual and interethni ...... nd glucuronidation of codeine.
@en
Interindividual and interethni ...... nd glucuronidation of codeine.
@nl
P2093
P2860
P1476
Interindividual and interethni ...... nd glucuronidation of codeine.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1989.TB03555.X
P407
P577
1989-12-01T00:00:00Z